Sara Badreh
Overview
Explore the profile of Sara Badreh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
210
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Horgan D, Van Den Bulcke M, Malapelle U, Normanno N, Capoluongo E, Prelaj A, et al.
Curr Oncol
. 2024 Apr;
31(4):1839-1864.
PMID: 38668042
Understanding the diversity in cancer research priorities and the correlations among different treatment modalities is essential to address the evolving landscape of oncology. This study, conducted in collaboration with the...
2.
Horgan D, Van Den Bulcke M, Malapelle U, Normanno N, Capoluongo E, Prelaj A, et al.
Healthcare (Basel)
. 2024 Jan;
12(2).
PMID: 38275541
Improvements in cancer care require a new degree of collaboration beyond the purely medical sphere, extending deeply into the world of other stakeholders-preeminently patients but also the other stakeholders in...
3.
Alunno A, Avcin T, Haines C, Ramiro S, Sivera F, Badreh S, et al.
Ann Rheum Dis
. 2023 May;
82(8):1107-1113.
PMID: 37188497
Background: Postgraduate rheumatology training programmes are already established at a national level in most European countries. However, previous work has highlighted a substantial level of heterogeneity in the organisation and,...
4.
de Thurah A, Bosch P, Marques A, Meissner Y, Mukhtyar C, Knitza J, et al.
Ann Rheum Dis
. 2022 Apr;
81(8):1065-1071.
PMID: 35470160
Background: Remote care and telehealth have the potential to expand healthcare access, and the COVID-19 pandemic has called for alternative solutions to conventional face-to-face follow-up and monitoring. However, guidance is...
5.
Drosos G, Vedder D, Houben E, Boekel L, Atzeni F, Badreh S, et al.
Ann Rheum Dis
. 2022 Feb;
81(6):768-779.
PMID: 35110331
Objective: To develop recommendations for cardiovascular risk (CVR) management in gout, vasculitis, systemic sclerosis (SSc), myositis, mixed connective tissue disease (MCTD), Sjögren's syndrome (SS), systemic lupus erythematosus (SLE) and antiphospholipid...
6.
Virgone A, Badreh S
Cancers (Basel)
. 2021 Sep;
13(17).
PMID: 34503221
The early diagnosis and management of oral potentially malignant disorders (OPMD) represent a unique opportunity to develop strategies that will prevent malignant transformation. Despite a high prevalence, awareness remains low,...
7.
Sivera F, Alunno A, Najm A, Avcin T, Baraliakos X, Bijlsma J, et al.
Ann Rheum Dis
. 2020 Aug;
80(1):65-70.
PMID: 32788400
Background And Aim: Striving for harmonisation of specialty training and excellence of care in rheumatology, the European League Against Rheumatism (EULAR) established a task force to develop points to consider...
8.
Steen J, Forsstrom B, Sahlstrom P, ODowd V, Israelsson L, Krishnamurthy A, et al.
Arthritis Rheumatol
. 2018 Aug;
71(2):196-209.
PMID: 30152202
Objective: Antibodies against posttranslationally modified proteins are a hallmark of rheumatoid arthritis (RA), but the emergence and pathogenicity of these autoantibodies are still incompletely understood. The aim of this study...